Context Therapeutics Inc. (CNTX)
NASDAQ: CNTX · Real-Time Price · USD
0.7000
+0.0200 (2.94%)
At close: Aug 13, 2025, 4:00 PM
0.7299
+0.0299 (4.27%)
After-hours: Aug 13, 2025, 6:43 PM EDT
Context Therapeutics Market Cap
Context Therapeutics has a market cap or net worth of $62.79 million as of August 13, 2025. Its market cap has decreased by -63.44% in one year.
Market Cap
62.79M
Enterprise Value
-20.56M
1-Year Change
-63.44%
Ranking
Category
Stock Price
$0.70
Market Cap Chart
Since the IPO on October 20, 2021, Context Therapeutics's market cap has increased from $51.03M to $62.79M, an increase of 23.06%. That is a compound annual growth rate of 5.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 62.79M | -33.33% |
| Dec 31, 2024 | 94.19M | 422.07% |
| Dec 29, 2023 | 18.04M | 73.39% |
| Dec 30, 2022 | 10.41M | -75.50% |
| Dec 31, 2021 | 42.46M | -16.78% |
| Oct 20, 2021 | 51.03M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 574.04B |
| Johnson & Johnson | 416.11B |
| AbbVie | 350.91B |
| UnitedHealth Group | 236.90B |
| AstraZeneca | 232.33B |
| Novartis AG | 230.64B |
| Abbott Laboratories | 228.03B |
| Novo Nordisk | 223.00B |